What is AKASA?
AI automation for healthcare revenue-cycle operations.
- Category
- Revenue-cycle AI
- Headquarters
- South San Francisco, California
- Founded
- 2019
- Employees
- Private; LinkedIn and press describe a mid-sized U.S. team
- Total funding
- About $205 million disclosed
- Status
- Private
What is AKASA?
AKASA is a revenue-cycle ai company headquartered in South San Francisco, California.
AKASA builds AI-powered automation for health-system revenue-cycle tasks such as prior authorization, claim status, denials, and coding support. Reported customers include large provider organizations and health systems using AKASA to automate administrative workflows.
The company was founded in 2019 and remains private. Its public profile is strongest around Unified Automation Platform and Prior authorization automation, while detailed revenue figures are not publicly disclosed.
As of June 2026, the safest public read is that AKASA is scaling through enterprise partnerships and capital-intensive product development rather than a self-serve consumer motion.
Sources:AKASA websiteAKASA company news
What does AKASA offer?
AKASA's public product set centers on Unified Automation Platform, Prior authorization automation, Claim-status automation.
- Unified Automation Platform· Revenue cycle
- Prior authorization automation· Administrative AI
- Claim-status automation· Revenue cycle
- Generative AI coding support· Clinical admin
Sources:AKASA website
How does AKASA make money?
Enterprise SaaS and automation services for health systems; public pricing is not disclosed.
Enterprise SaaS and automation services for health systems; public pricing is not disclosed. No public list pricing; sold through health-system procurement.
Growth is driven by enterprise adoption, strategic partnerships, and proof that the platform can deliver measurable operational, clinical, scientific, or mission outcomes. Because AKASA does not publish standard list prices, buyers should treat budget sizing as a custom-contract exercise.
The commercial motion therefore depends on executive sponsorship, security and compliance review, and evidence that the product can integrate into existing workflows rather than replace them all at once.
Sources:AKASA websiteForbes AI 50
Who leads AKASA?
AKASA is led by Malinka Walaliyadde, Co-founder and CEO.
- Malinka WalaliyaddeCo-founder and CEOCo-founder · since 2019Former investor and operator leading revenue-cycle automation strategy.
- Varun GanapathiCo-founder and CTOCo-founder · since 2019Computer scientist leading AI and automation technology.
- Ben Beadle-RybyCo-founderCo-founder · since 2019Revenue-cycle operator and company builder.
How do you contact AKASA's leadership?
Public contact form; no verified personal email pattern found. Use the listed public company route rather than guessed personal inboxes.
Public contact form; no verified personal email pattern foundSources:AKASA website
How much funding has AKASA raised?
AKASA has about $205 million disclosed and is private.
2020: Series A — $15 million, led/backed by Andreessen Horowitz. 2021: Series B — $60 million, led/backed by Bond. 2022: Series C — $60 million, led/backed by Samaipata and existing investors. 2023: Growth financing — $70 million, led/backed by Reported venture investors (Valuation undisclosed).
The latest public valuation/status marker is Undisclosed. Where a valuation is undisclosed, public reporting only supports the financing amount and participating investors.
Funding is best interpreted as capacity for product build-out, hiring, regulatory or deployment work, and longer sales cycles; it should not be read as proof of profitability unless the company has separately disclosed profitability.
How did AKASA get here?
AKASA's timeline runs from its 2019 founding through major financing and product milestones.
- 2019FoundedAKASA was created to automate healthcare revenue-cycle operations.
- 2020Series AThe company raised institutional funding for RCM automation.
- 2021Series BAKASA expanded its automation platform for health systems.
- 2022Series CThe company raised additional capital as labor shortages stressed revenue-cycle teams.
- 2024Generative AI expansionAKASA positioned generative AI as part of its administrative workflow product set.
Sources:AKASA websiteAKASA company news
Who are AKASA's competitors?
AKASA competes with specialized startups and larger platform companies in revenue-cycle ai.
- CedarPatient financial engagement and billing platform.
- R1 RCMLarge outsourced revenue-cycle management provider.
- WaystarHealthcare payments and revenue-cycle software.
- Infinitus SystemsVoice AI agents for payer and pharma workflows.
Sources:AKASA websiteForbes AI 50
AKASA — frequently asked questions
